Illness never sleeps, so neither do we.
From rising rates of diseases like diabetes and cancer to the shock of rare disease diagnosis,
From managing a long-term illness to facing the challenge of age-related conditions like dementia,
Illness can be relentless.
But #WeWontRest in our quest to discover and develop new medicines for patients in Europe.
It is what keeps us up at night. It is what drives us.
And with over 7,000 new medicines in development, #WeWontRest until we’ve helped make Europe a healthier place for everyone
See more of the We Won’t Rest story.
The Pledge Wall
Stefan Oelrich, GermanyMember of the Board of Management Bayer AG & President Pharmaceuticals, Bayer
#WeWontRest until patients can play a truly active role in the development of their medicinesRead more
IPSEN Team, Italy
#WeWontRest until we address the issues facing patients with Rare DiseasesRead more
Chito Zulueta, Indiana, USASenior VP and President of Lilly International, Eli Lilly and Company
#WeWontRest until the view of patients is heard in the Health Technology Assessment (HTA) process. Having a final HTA decision without letting patients provide their perspective is not a complete processRead more
Within the next 5 years cutting edge developments in medicine will transform the lives of patients. These are the 9 therapy areas set to make the biggest difference.View All